Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-018889
Filing Date
2025-02-28
Accepted
2025-02-28 18:03:39
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4041
  Complete submission text file 0001213900-25-018889.txt   5600
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Issuer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SHORE ACCOUNTANTS MD INC. 115 PULLMAN CROSSING ROAD, SUITE 103 GRASONVILLE MD 21638
Business Address
Romness Paul A. (Reporting) CIK: 0001974517 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42195 | Film No.: 25692719